Drug
Intravenous vitamin C
Intravenous vitamin C is a pharmaceutical drug with 4 clinical trials. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_2
1
25%
Ph phase_1
2
50%
Ph not_applicable
1
25%
Phase Distribution
2
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(2)
Detailed Status
Completed2
Withdrawn1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 2
Trials by Phase
Phase 12 (50.0%)
Phase 21 (25.0%)
N/A1 (25.0%)
Trials by Status
withdrawn125%
terminated125%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
terminatedphase_2
Pilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL)
NCT00626444
completedphase_1
Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer
NCT00954525
completedphase_1
New Treatment Option for Pancreatic Cancer
NCT01364805
withdrawnnot_applicable
The Effect of High Dose Vitamin C in Burn Patients
NCT00350077
Clinical Trials (4)
Showing 4 of 4 trials
NCT00626444Phase 2
Pilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL)
NCT00954525Phase 1
Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer
NCT01364805Phase 1
New Treatment Option for Pancreatic Cancer
NCT00350077Not Applicable
The Effect of High Dose Vitamin C in Burn Patients
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4